Can preoperative lymphoscintigraphy be used as a guide in treatment planning of breast cancer?

Clinical Nuclear Medicine

Volumn 26, Issue 5, 2001, Pages 405-411

  Mudun, Ayse ^a,b   Aslay, Isik ^a   Aygen, Muge ^a   Muslumanoglu, Mahmut ^a   Bozfakioglu, Yavuz ^a   Cantez, Sema ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast Cancer; Lymphatic Mapping; Lymphoscintigraphy; Tc 99m Rhenium Sulfide Colloid

Indexed keywords

RHENIUM TECHNETIUM TC 99M; TCK 17;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLLIMATOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MASTECTOMY; PREOPERATIVE EVALUATION; SCINTILLATION CAMERA; TREATMENT PLANNING; TUMOR BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0035031376     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200105000-00007     Document Type: Article

References (36)

1. Mammary lymphoscintigraphy in breast cancer
2. Breast stage T1 and T2 tumors
3. To treat or not to treat internal mammary nodes. A possible compromise
4. Long term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes
5. Postmastectomy megavoltage radiotherapy. The Oslo and Stockholm Trials
6. Radiation therapy in operable breast cancer: Results from the Stockholm trial on adjuvant radiotherapy
7. Evaluation of irradiated heart volume in stage I breast cancer patients treated with postoperative adjuvant radiotherapy
8. Postoperative radiotherapy in high risk premenopausal women with breast cancer
9. Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes
10. Technical details of intraoperative lymphatic mapping for early stage melanoma
11. Gamma probe guided localization of lymph nodes
12. Gamma probe guided lymph node localisation in melanoma
13. Lymphoscintigraphy in high risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node
14. Early stage melanoma: Lymphoscintigraphy, reproducibility of sentinel node detection and effectiveness of the intraoperative gamma probe
15. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
16. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe
17. Impact of lymphoscintigraphy on sentinel node identification with Tc99m-colloid albumin in breast cancer
18. Can axillary dissection be avoided in breast cancer?
19. Sentinel lymph node localization in early breast cancer
20. Lymphatic mapping and sentinel node biopsy in breast cancer
21. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
22. Evaluation of radiotherapy in high risk breast cancer patients. Report from the Danish Breast Cancer Cooperative group (DBCG 82) Trial
23. Consensus statement on postmastectomy radiation therapy
24. The return of postmastectomy radiotherapy
25. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes?
26. Inefficacy of internal mammary nodes dissection in breast cancer surgery
27. Overview of randomised trials of postoperative adjuvant radiotherapy in breast cancer
28. Prediction of excess risk of long term cardiac mortality after radiotherapy of stage I breast cancer
29. Limitation in gamma probe localisation of the sentinel node in breast cancer patients with large excisional biopsy
30. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer and other potential cancers
31. Technetium99m-sulfur colloid for lymphoscintigraphy: Effects of preparation parameters
32. Particle size evaluation of Tc99m-TCK-17. A potential new radiopharmaceutical for lymphoscintigraphy studies